ADCT Stock Analysis: Buy, Sell, or Hold?
ADCT - ADC Therapeutics SA
$3.36
-0.12 (-3.45%)
▼
5d:
-10.4%
30d:
-23.11%
90d:
-16.42%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 04, 2026
0d
Smart Money Accumulation
ADCT is down 10.4% this week, but smart money is accumulating calls. Top strike: $5 2026-07-17 with 321 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When ADCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ADCT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ADCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ADCT is currently trading at $3.36, which is considered slightly low relative to its 30-day fair value range of $3.65 to $4.10.
Technical Outlook: Technically, ADCT is showing sideways momentum. The price is currently testing key support at $3.36. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: ADCT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.20 (+144.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADCT is showing sideways momentum. The price is currently testing key support at $3.36. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: ADCT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.20 (+144.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.65 -
$4.10
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 144.0% below Wall St target ($8.20)
- CAUTION: 5-day price weakness (-10.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$3.65 -
$4.10
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.36
Resistance Level
$4.13
Current Trend
Sideways
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.44
Wall Street Target
$8.20
(+144.0%)
Revenue Growth (YoY)
-9.5%
Profit Margin
-173.0%
Share & Embed Analysis
Last updated: May 14, 2026 6:30 PM ET
Data refreshes hourly during market hours. Next update: 7:30 PM
Data refreshes hourly during market hours. Next update: 7:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Redmile Group, Llc
SELL
2529491 shares
2026-04-02
Redmile Group, Llc
SELL
2634506 shares
2026-04-02
Redmile Group, Llc
SELL
162517 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 66 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$104 | 60 BUY |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 54 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$181 | 59 HOLD |
